It's not underfunding of drug research and development. It's the FDA restrictions, which have been relaxed for this drug, and they've been expedited through the

It's not underfunding of drug research and development. It's the FDA restrictions, which have been relaxed for this drug, and they've been expedited through the approval process. So maybe more funding for FDA, contingent upon them speeding up the process.